Gel electrophoretic methods for the analysis of biosimilar pharmaceuticals using the example of recombinant erythropoietin

Bioanalysis ◽  
2013 ◽  
Vol 5 (5) ◽  
pp. 587-602 ◽  
Author(s):  
Christian Reichel ◽  
Mario Thevis
Keyword(s):  
Recombinant Erythropoietin ◽  
Biosimilar Pharmaceuticals

Clinical Application of Recombinant Erythropoietin in Predialysis Renal Failure

1994 ◽  
Vol 8 (5) ◽  
pp. 927-932
Author(s):  
William A. Briggs ◽  
Luis F. Gimenez
Keyword(s):  
Renal Failure ◽  
Clinical Application ◽  
Recombinant Erythropoietin

Receptors for recombinant erythropoietin in human bone marrow cells

1987 ◽  
Vol 47 (8) ◽  
pp. 823-827 ◽  
Author(s):  
K. Rosenlof ◽  
F. Fyhrquist ◽  
F. Pekonen
Keyword(s):  
Bone Marrow ◽  
Bone Marrow Cells ◽  
Human Bone ◽  
Human Bone Marrow ◽  
Recombinant Erythropoietin ◽  
Marrow Cells

Successful recombinant erythropoietin therapy for a developing anemic newborn with hereditary spherocytosis

2006 ◽  
Vol 48 (2) ◽  
pp. 178-180 ◽  
Author(s):  
SHIGEHARU HOSONO ◽  
AKO HOSONO ◽  
HIDEO MUGISHIMA ◽  
YUKO NAKANO ◽  
MICHIYOSHI MINATO ◽  
...  
Keyword(s):  
Hereditary Spherocytosis ◽  
Recombinant Erythropoietin

scholarly journals Infantile Pyknocytosis: End-Tidal CO, %Micro-R Measurements, Next-Generation Sequencing, and Transfusion Avoidance with Darbepoetin

2020 ◽  
Vol 5 (3) ◽  
pp. 1-8
Author(s):  
Timothy M. Bahr ◽  
Mari C. Knudsen ◽  
Michell Lozano-Chinga ◽  
Archana M. Agarwal ◽  
Jessica A. Meznarich ◽  
...  
Keyword(s):  
Next Generation Sequencing ◽  
Hemolytic Anemia ◽  
Clinical Course ◽  
Recombinant Erythropoietin ◽  
Next Generation ◽  
Good Outcome ◽  
End Tidal ◽  
Generation Sequencing

Infantile pyknocytosis is a rare, self-limited, hemolytic condition of unknown pathogenesis. It is diagnosed when a neonate with Coombs-negative hemolytic anemia has abundant pyknocytes and a characteristic clinical course after other hemolytic disorders has been excluded. Previous reports suggest that transfusions might be avoidable in this condition by administering recombinant erythropoietin. We cared for a patient with this disorder where we employed novel diagnostics and therapeutics. Despite these, and a good outcome free of transfusions, we continue to consider the condition to be idiopathic.

Recombinant-erythropoietin

2021 ◽  
Vol 1844 (1) ◽  
pp. 390-390
Keyword(s):  
Recombinant Erythropoietin

scholarly journals Switching to an alternative recombinant erythropoietin agent in patients with myelodysplastic syndromes: a second honeymoon ?

2021 ◽  
Author(s):  
Bruno Fattizzo ◽  
Lorenzo Rizzo ◽  
Juri Alessandro Giannotta ◽  
Federico Mazzon ◽  
Nicola Cecchi ◽  
...  
Keyword(s):  
Myelodysplastic Syndromes ◽  
Recombinant Erythropoietin

Response to recombinant erythropoietin alpha, without the adjunct of granulocyte-colony stimulating factor, is associated with a longer survival in patients with transfusion-dependent myelodysplastic syndromes

2010 ◽  
Vol 34 (8) ◽  
pp. 981-985 ◽  
Author(s):  
Pellegrino Musto ◽  
Oreste Villani ◽  
Maria Carmen Martorelli ◽  
Giuseppe Pietrantuono ◽  
Roberto Guariglia ◽  
...  
Keyword(s):  
Myelodysplastic Syndromes ◽  
Recombinant Erythropoietin ◽  
Granulocyte Colony Stimulating Factor ◽  
Colony Stimulating Factor ◽  
Stimulating Factor

Recombinant Erythropoietin

1991 ◽  
Vol 12 (8) ◽  
pp. 244-248 ◽  
Author(s):  
R. D. Christensen
Keyword(s):  
Recombinant Erythropoietin
Sign in / Sign up

Export Citation Format

Share Document